Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07466628) titled 'Effects of Caffeine Ingestion on Morning Cognitive and Muscle Strength Measures in Males' on Feb. 25.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Liverpool John Moores University
Condition:
Caffine
Placebo - Control
No Pill
Intervention:
Drug: 300mg of of caffeine anhydrous in 3 capsules similar to PLACEBO in size and weight
Other: Placebo
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: November 15, 2024
Target Sample Size: 1...